Glenmede Trust CO Na Agilent Technologies, Inc. Transaction History

Glenmede Trust CO Na

  • $20.6 Billion
  • Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 114,638 shares of A stock, worth $14.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
114,638
Previous 74,407 54.07%
Holding current value
$14.9 Million
Previous $9.65 Million 76.47%
% of portfolio
0.08%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$125.42 - $148.48 $5.05 Million - $5.97 Million
40,231 Added 54.07%
114,638 $17 Million
Q2 2024

Aug 14, 2024
BUY
$129.63 - $154.64 $7.29 Million - $8.69 Million
56,214 Added 308.99%
74,407 $9.65 Million
Q1 2024

May 15, 2024
BUY
$128.12 - $149.31 $1.5 Million - $1.75 Million
11,733 Added 181.63%
18,193 $2.65 Million
Q4 2023

Feb 13, 2024
SELL
$101.17 - $139.82 $496,744 - $686,516
-4,910 Reduced 43.18%
6,460 $898,000
Q3 2023

Nov 14, 2023
SELL
$109.73 - $128.47 $22 Million - $25.7 Million
-200,077 Reduced 94.62%
11,370 $1.27 Million
Q2 2023

Aug 14, 2023
SELL
$114.69 - $141.28 $20,988 - $25,854
-183 Reduced 0.09%
211,447 $25.4 Million
Q1 2023

May 15, 2023
SELL
$131.13 - $159.06 $2.6 Million - $3.15 Million
-19,798 Reduced 8.55%
211,630 $29.3 Million
Q4 2022

Feb 14, 2023
SELL
$125.64 - $157.68 $18.4 Million - $23.1 Million
-146,384 Reduced 38.75%
231,428 $34.6 Million
Q3 2022

Nov 16, 2022
SELL
$115.11 - $142.29 $7.86 Million - $9.72 Million
-68,279 Reduced 15.31%
377,812 $45.9 Million
Q2 2022

Aug 15, 2022
BUY
$112.71 - $135.93 $17.3 Million - $20.9 Million
153,770 Added 52.6%
446,091 $53 Million
Q1 2022

May 16, 2022
BUY
$126.0 - $156.48 $812,448 - $1.01 Million
6,448 Added 2.26%
292,321 $38.7 Million
Q4 2021

Feb 15, 2022
BUY
$147.95 - $164.3 $364,992 - $405,328
2,467 Added 0.87%
285,873 $45.6 Million
Q3 2021

Nov 15, 2021
SELL
$147.58 - $179.28 $473,584 - $575,309
-3,209 Reduced 1.12%
283,406 $44.6 Million
Q2 2021

Aug 16, 2021
SELL
$127.69 - $148.81 $949,630 - $1.11 Million
-7,437 Reduced 2.53%
286,615 $42.4 Million
Q1 2021

May 18, 2021
BUY
$114.99 - $130.12 $32.5 Million - $36.7 Million
282,399 Added 2423.4%
294,052 $37.4 Million
Q4 2020

Feb 16, 2021
BUY
$100.01 - $119.3 $11,001 - $13,123
110 Added 0.95%
11,653 $1.38 Million
Q3 2020

Nov 16, 2020
SELL
$88.11 - $103.42 $122,913 - $144,270
-1,395 Reduced 10.78%
11,543 $1.16 Million
Q2 2020

Aug 14, 2020
SELL
$68.92 - $91.14 $2.14 Million - $2.82 Million
-30,981 Reduced 70.54%
12,938 $1.14 Million
Q4 2019

Feb 12, 2020
BUY
$72.49 - $85.45 $92,352 - $108,863
1,274 Added 2.99%
43,919 $3.75 Million
Q3 2019

Nov 14, 2019
SELL
$65.59 - $78.07 $259,408 - $308,766
-3,955 Reduced 8.49%
42,645 $3.27 Million
Q2 2019

Aug 13, 2019
SELL
$66.89 - $81.94 $1.86 Million - $2.28 Million
-27,777 Reduced 37.35%
46,600 $3.48 Million
Q1 2019

May 14, 2019
SELL
$63.27 - $82.0 $101,232 - $131,200
-1,600 Reduced 2.11%
74,377 $5.98 Million
Q4 2018

Feb 14, 2019
SELL
$61.13 - $74.67 $14.2 Million - $17.3 Million
-232,132 Reduced 75.34%
75,977 $5.12 Million
Q3 2018

Nov 15, 2018
SELL
$61.25 - $71.13 $8.56 Million - $9.94 Million
-139,775 Reduced 31.21%
308,109 $21.7 Million
Q2 2018

Aug 15, 2018
BUY
$61.14 - $69.55 $1.21 Million - $1.37 Million
19,716 Added 4.6%
447,884 $27.7 Million
Q4 2017

Feb 15, 2018
BUY
$64.87 - $70.59 $103,143 - $112,238
1,590 Added 0.37%
428,168 $28.7 Million
Q3 2017

Nov 14, 2017
BUY
$58.57 - $66.17 $25 Million - $28.2 Million
426,578
426,578 $0

Others Institutions Holding A

# of Institutions
1,148
Shares Held
253M
Call Options Held
974K
Put Options Held
939K
View Full List

About AGILENT TECHNOLOGIES, INC.

A Quotes by TradingView
  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $38.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email